AngioDynamics to Hold Fiscal 2007 Fourth Quarter and Full-Year Financial Results Conference Call on Tuesday, July 24, 2007
Eamonn P. Hobbs, president and chief executive officer, and Joseph Gersuk, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern time on July 24th to discuss these results and to answer questions.
To participate in the live call by telephone, please dial (888) 713-4209 from the U.S., or for international callers, please dial (617) 213-4863. Please enter the passcode: 25543109.
Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' website at http://investor.angiodynamics.com. To listen to the live call, please go to the website 15 minutes prior to its start to register, download, and install the necessary audio software.
A replay will be available on the website. A telephone replay will be available from 6:30 p.m. Eastern time on July 24, 2007 through 11:59 p.m. Eastern time on July 31 by dialing (888) 286-8010 (domestic) or (617) 801-6888 (international) and entering the passcode: 16976535.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.
CONTACT: AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Investor Relations:
Jennifer Beugelmans, 646-201-5447
jbeugelmans@evcgroup.com
Doug Sherk, 646-201-5447
dsherk@evcgroup.com
Media:
Steve DiMattia, 646-201-5445
sdimattia@evcgroup.com
SOURCE: AngioDynamics, Inc.